Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management

JS Knight, DW Branch, TL Ortel - bmj, 2023 - bmj.com
Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease propelled by
circulating autoantibodies that recognize cell surface phospholipids and phospholipid …

From co-infections to autoimmune disease via hyperactivated innate immunity: COVID-19 autoimmune coagulopathies, autoimmune myocarditis and multisystem …

R Root-Bernstein - International Journal of Molecular Sciences, 2023 - mdpi.com
Neutrophilia and the production of neutrophil extracellular traps (NETs) are two of many
measures of increased inflammation in severe COVID-19 that also accompany its …

Classification criteria for the antiphospholipid syndrome: not the same as diagnostic criteria for antiphospholipid syndrome

EJ Favaloro, L Pasalic, G Lippi - Seminars in Thrombosis and …, 2023 - thieme-connect.com
The latest consensus “guidelines” outlining revised Classification Criteria for
antiphospholipid syndrome (APS) has just been published. 1 The aim of this publication was …

Close link between antiphosphatidylserine/prothrombin antibodies, lupus anticoagulant, and activated protein C resistance in tetra antiphospholipid antibody–positive …

E Pontara, E Bison, MG Cattini, M Tonello… - Journal of Thrombosis …, 2023 - Elsevier
Background Most of the carriers/patients triple-positive for antiphospholipid antibodies
(lupus anticoagulant [LAC], immunoglobulin G [IgG]/immunoglobulin M [IgM] anticardiolipin …

[HTML][HTML] Added value of antiphosphatidylserine/prothrombin antibodies in the workup of obstetric antiphospholipid syndrome: communication from the ISTH SSC …

A Vandevelde, JC Gris, GW Moore, J Musiał… - Journal of Thrombosis …, 2023 - Elsevier
Background The added value of antiphosphatidylserine/prothrombin antibodies (aPS/PT) in
the diagnostic workup of antiphospholipid syndrome (APS) is unclear. Currently, diagnosis …

Application of the thrombin generation assay in patients with antiphospholipid syndrome: A systematic review of the literature

R Gehlen, A Vandevelde, B de Laat… - Frontiers in …, 2023 - frontiersin.org
Background The antiphospholipid syndrome (APS) is classified by the presence of
antiphospholipid antibodies (aPL) and thrombotic and/or adverse obstetric outcomes. The …

Guidelines on the investigation and management of antiphospholipid syndrome

DJ Arachchillage, S Platton… - British journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Guidelines on the investigation and management of antiphospholipid syndrome Guidelines
on the investigation and management of antiphospholipid syndrome Br J Haematol. 2024 Jul …

Laboratory testing for non-criteria antiphospholipid antibodies: anti-phosphatidylserine/prothrombin antibodies (aPS/PT)

KMJ Devreese - Hemostasis and Thrombosis: Methods and Protocols, 2023 - Springer
Since the discovery that antiphospholipid antibodies (aPL) bind to a cofactor at the
phospholipid membrane, the proteins beta-2-glycoprotein I (β2GPI) and prothrombin …

Non-criteria autoantibodies in antiphospholipid syndrome may be associated with underlying disease activity

P Akyüz Dağlı, A Erden, H Babaoğlu, Ö Karakaş… - Irish Journal of Medical …, 2024 - Springer
Background Antiphospholipid syndrome (APS) is a systemic autoimmune disorder
characterized by persistent antiphospholipid antibodies (aPLs) with arterial and venous …

Epidemiology of antiphospholipid syndrome: macro-and microvascular manifestations

P Gaspar, S Sciascia, MG Tektonidou - Rheumatology, 2024 - academic.oup.com
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
thrombotic and non-thrombotic macro-and microvascular manifestations and pregnancy …